Logo image of CPSS

CONSUMER PORTFOLIO SERVICES (CPSS) Stock Fundamental Analysis

NASDAQ:CPSS - Nasdaq - US2105021008 - Common Stock - Currency: USD

9.41  -0.14 (-1.47%)

After market: 9.41 0 (0%)

Fundamental Rating

3

Overall CPSS gets a fundamental rating of 3 out of 10. We evaluated CPSS against 53 industry peers in the Consumer Finance industry. CPSS has a bad profitability rating. Also its financial health evaluation is rather negative. CPSS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CPSS had positive earnings in the past year.
CPSS had a positive operating cash flow in the past year.
In the past 5 years CPSS has always been profitable.
Of the past 5 years CPSS 4 years had a positive operating cash flow.
CPSS Yearly Net Income VS EBIT VS OCF VS FCFCPSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

1.2 Ratios

CPSS has a Return On Assets of 0.61%. This is in the lower half of the industry: CPSS underperforms 64.15% of its industry peers.
CPSS has a Return On Equity (7.45%) which is comparable to the rest of the industry.
With a Return On Invested Capital value of 0.17%, CPSS perfoms like the industry average, outperforming 43.40% of the companies in the same industry.
CPSS had an Average Return On Invested Capital over the past 3 years of 1.36%. This is significantly below the industry average of 7.73%.
Industry RankSector Rank
ROA 0.61%
ROE 7.45%
ROIC 0.17%
ROA(3y)1.75%
ROA(5y)1.69%
ROE(3y)20.24%
ROE(5y)20.98%
ROIC(3y)1.36%
ROIC(5y)1.73%
CPSS Yearly ROA, ROE, ROICCPSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of CPSS (5.93%) is worse than 67.92% of its industry peers.
In the last couple of years the Profit Margin of CPSS has grown nicely.
Looking at the Operating Margin, with a value of 2.21%, CPSS is doing worse than 60.38% of the companies in the same industry.
In the last couple of years the Operating Margin of CPSS has declined.
Looking at the Gross Margin, with a value of 50.02%, CPSS is in line with its industry, outperforming 52.83% of the companies in the same industry.
CPSS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.21%
PM (TTM) 5.93%
GM 50.02%
OM growth 3Y-59.4%
OM growth 5Y-8.29%
PM growth 3Y-33.4%
PM growth 5Y26.98%
GM growth 3Y-12.4%
GM growth 5Y-6.49%
CPSS Yearly Profit, Operating, Gross MarginsCPSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1

2. Health

2.1 Basic Checks

CPSS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CPSS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CPSS has been reduced compared to 5 years ago.
The debt/assets ratio for CPSS is higher compared to a year ago.
CPSS Yearly Shares OutstandingCPSS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CPSS Yearly Total Debt VS Total AssetsCPSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

CPSS has an Altman-Z score of 0.24. This is a bad value and indicates that CPSS is not financially healthy and even has some risk of bankruptcy.
CPSS has a worse Altman-Z score (0.24) than 60.38% of its industry peers.
CPSS has a debt to FCF ratio of 14.04. This is a negative value and a sign of low solvency as CPSS would need 14.04 years to pay back of all of its debts.
CPSS's Debt to FCF ratio of 14.04 is in line compared to the rest of the industry. CPSS outperforms 41.51% of its industry peers.
CPSS has a Debt/Equity ratio of 10.89. This is a high value indicating a heavy dependency on external financing.
CPSS's Debt to Equity ratio of 10.89 is on the low side compared to the rest of the industry. CPSS is outperformed by 88.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 10.89
Debt/FCF 14.04
Altman-Z 0.24
ROIC/WACC0.03
WACC4.86%
CPSS Yearly LT Debt VS Equity VS FCFCPSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

CPSS has a Current Ratio of 0.22. This is a bad value and indicates that CPSS is not financially healthy enough and could expect problems in meeting its short term obligations.
CPSS's Current ratio of 0.22 is on the low side compared to the rest of the industry. CPSS is outperformed by 71.70% of its industry peers.
CPSS has a Quick Ratio of 0.22. This is a bad value and indicates that CPSS is not financially healthy enough and could expect problems in meeting its short term obligations.
CPSS has a Quick ratio of 0.22. This is in the lower half of the industry: CPSS underperforms 71.70% of its industry peers.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.22
CPSS Yearly Current Assets VS Current LiabilitesCPSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 101.10% over the past year.
Measured over the past years, CPSS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.62% on average per year.
Looking at the last year, CPSS shows a quite strong growth in Revenue. The Revenue has grown by 9.54% in the last year.
Measured over the past years, CPSS shows a decrease in Revenue. The Revenue has been decreasing by -8.41% on average per year.
EPS 1Y (TTM)101.1%
EPS 3Y53.09%
EPS 5Y12.62%
EPS Q2Q%-26.62%
Revenue 1Y (TTM)9.54%
Revenue growth 3Y-11.28%
Revenue growth 5Y-8.41%
Sales Q2Q%22.48%

3.2 Future

Based on estimates for the next years, CPSS will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.35% on average per year.
CPSS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.59% yearly.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3Y-22.04%
EPS Next 5Y10.35%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3Y13.54%
Revenue Next 5Y15.59%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CPSS Yearly Revenue VS EstimatesCPSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
CPSS Yearly EPS VS EstimatesCPSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.14, the valuation of CPSS can be described as very cheap.
96.23% of the companies in the same industry are more expensive than CPSS, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 29.35, CPSS is valued rather cheaply.
Industry RankSector Rank
PE 5.14
Fwd PE N/A
CPSS Price Earnings VS Forward Price EarningsCPSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CPSS.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CPSS indicates a rather cheap valuation: CPSS is cheaper than 92.45% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.91
EV/EBITDA 373.96
CPSS Per share dataCPSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CPSS's earnings are expected to decrease with -22.04% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.41
EPS Next 2YN/A
EPS Next 3Y-22.04%

0

5. Dividend

5.1 Amount

No dividends for CPSS!.
Industry RankSector Rank
Dividend Yield N/A

CONSUMER PORTFOLIO SERVICES

NASDAQ:CPSS (3/7/2025, 8:16:03 PM)

After market: 9.41 0 (0%)

9.41

-0.14 (-1.47%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)02-25 2025-02-25/amc
Earnings (Next)05-08 2025-05-08
Inst Owners26.3%
Inst Owner Change0.26%
Ins Owners35.86%
Ins Owner Change-4.38%
Market Cap201.47M
Analysts85.71
Price Target18.36 (95.11%)
Short Float %4.05%
Short Ratio12.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)3.99%
Revenue NY rev (3m)3.99%
Valuation
Industry RankSector Rank
PE 5.14
Fwd PE N/A
P/S 0.56
P/FCF 0.91
P/OCF 0.91
P/B 0.71
P/tB 0.71
EV/EBITDA 373.96
EPS(TTM)1.83
EY19.45%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)10.33
FCFY109.81%
OCF(TTM)10.36
OCFY110.11%
SpS16.73
BVpS13.32
TBVpS13.32
PEG (NY)N/A
PEG (5Y)0.41
Profitability
Industry RankSector Rank
ROA 0.61%
ROE 7.45%
ROCE 0.23%
ROIC 0.17%
ROICexc 0.17%
ROICexgc 0.17%
OM 2.21%
PM (TTM) 5.93%
GM 50.02%
FCFM 61.76%
ROA(3y)1.75%
ROA(5y)1.69%
ROE(3y)20.24%
ROE(5y)20.98%
ROIC(3y)1.36%
ROIC(5y)1.73%
ROICexc(3y)1.37%
ROICexc(5y)1.74%
ROICexgc(3y)1.38%
ROICexgc(5y)1.76%
ROCE(3y)1.89%
ROCE(5y)2.4%
ROICexcg growth 3Y-61.76%
ROICexcg growth 5Y-12.58%
ROICexc growth 3Y-61.73%
ROICexc growth 5Y-12.61%
OM growth 3Y-59.4%
OM growth 5Y-8.29%
PM growth 3Y-33.4%
PM growth 5Y26.98%
GM growth 3Y-12.4%
GM growth 5Y-6.49%
F-Score4
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 10.89
Debt/FCF 14.04
Debt/EBITDA 352.04
Cap/Depr 68.56%
Cap/Sales 0.17%
Interest Coverage 0.05
Cash Conversion 2514.89%
Profit Quality 1041.29%
Current Ratio 0.22
Quick Ratio 0.22
Altman-Z 0.24
F-Score4
WACC4.86%
ROIC/WACC0.03
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.1%
EPS 3Y53.09%
EPS 5Y12.62%
EPS Q2Q%-26.62%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3Y-22.04%
EPS Next 5Y10.35%
Revenue 1Y (TTM)9.54%
Revenue growth 3Y-11.28%
Revenue growth 5Y-8.41%
Sales Q2Q%22.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3Y13.54%
Revenue Next 5Y15.59%
EBIT growth 1Y-87.52%
EBIT growth 3Y-54.92%
EBIT growth 5Y-6.91%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-4.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.83%
OCF growth 3YN/A
OCF growth 5YN/A